| Revenue growth | Revenue grew 20% YoY, driven by Noida ramp-up and Lucknow maturity. |
|---|---|
| Margins | Consolidated EBITDA margin at 24.2%, impacted by early-stage Noida losses. |
| Demand visibility | Strong demand for tertiary care across UP, Bihar, and NCR regions. |
| Management confidence | Balanced and highly confident in clinical execution and expansion roadmap. |
Growth
Revenue grew 20% YoY to ₹45,089 million; EBITDA grew 19% excluding Noida losses. Quality is high, volume-led.
Outlook
Adding 500 beds to existing facilities and 2,700 beds via five greenfield projects by FY30.
Risks
Intense clinical talent competition in Gurgaon and initial operating losses from the aggressive new hospital pipeline.
Earnings Call filed with BSE, NSE: MEDANTA. Summary written with AI assistance from the document.
Global Health Ltd: key numbers
- Share price
- ₹1,294.10
- Market cap
- ₹34,795 Cr
- Revenue (annual)
- ₹4,410 Cr
- Net profit (annual)
- ₹556.5 Cr
- P/E (TTM)
- 62.6×Sector 53.1×
- Promoter holding
- 33.00%-0.01% QoQ
- FII holding
- 9.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Health Ltd
All →Global Health Employee Stock Options
Global Health Limited has allotted equity shares under its ESOP/ESPS scheme. This action results in a minor increase in the company's total paid-up share capital.
Global Health Employee Stock Options
Global Health Limited has allotted 3,000 equity shares under its employee stock option plan at a premium of Rs. 1,498 per share.
- Value
- ₹0.45 Cr
Global Health Annual General Meeting
Global Health Limited held its 22nd Annual General Meeting on September 16, 2026. The meeting covered financial statement adoption and shareholder dividend declaration.
Global Health Other Announcement
Global Health Limited has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as mandated by SEBI (LODR) regulations.
Global Health Annual General Meeting
Global Health Limited has announced its 22nd Annual General Meeting to be held on September 16, 2026, to consider financial statements, dividends, and director re-appointment.
- Value
- ₹0.12 Cr
Global Health Annual Report
Global Health Limited has submitted its Annual Report for the financial year 2025-26, alongside the notice for its 22nd Annual General Meeting.